Showing 8281-8290 of 9741 results for "".
- FDA Approves Enbrel Biosimilarhttps://practicaldermatology.com/news/fda-approves-enbrel-biosimilar/2458451/The U.S. Food and Drug Administration (FDA) approved Erelzi for multiple inflammatory diseases. Erelzi is a biosimilar to Enbrel (etanercept), which was originally licensed in 1998. The move is no surprise given the unanimous backing of an FDA advisory arm last month. There are now
- Hair Transplants Make Men Look Younger, Hotterhttps://practicaldermatology.com/news/hair-transplants-make-men-look-younger-hotter/2458450/Once-balding men who undergo hair transplants are seen as more youthful, attractive, successful and approachable, new research suggests. In 2014, hair transplant was among the most common cosmetic services sought by men, with more than 11, 000 procedures performed, according to info
- Cloudy with a Chance of Wrinkles: ROC Ranks US Cities By Wrinkle Indexhttps://practicaldermatology.com/news/cloudy-with-a-chance-of-wrinkles-roc-ranks-cities-by-wrinkle-index/2458453/Philadelphia will be the most wrinkle-prone city in America come 2040 thanks to high stress levels, more airborne pollution, lengthy commute times and higher than average smoking rates, according to the 2016 RoC® Wrinkle Ranking. San Jose, Calif. will hold the least wrinkle-pron
- 23andMe Data Helps ID BCC Risk Geneshttps://practicaldermatology.com/news/23andme-data-helps-id-bcc-risk-genes/2458459/New research out of 23andMe and Stanford University School of Medicine pinpoints 31 genetic associations for basal cell carcinoma (BCC), 14 of which are all new. Taken together, these associations are estimated to explain almost 11 percent of the genetic risk for BCC, according to t
- Fat Chance Teen Acne Doesn't Contain Diacylglycerolshttps://practicaldermatology.com/news/study-fat-chance-teen-acne-doesnt-contain-diacylglycerols/2458462/New research provides a fingerprint of the fats found in sebum, namely diacylglycerols. The findings appear in the Journal of Lipid Resea
- Most Indoor Tanners Not in Favor of #Banthetan Movementhttps://practicaldermatology.com/news/most-indoor-tanners-not-in-favor-of-banthetan-movement/2458464/Most young adult women who regularly visit indoor tanning salons do support the introduction of policies to make it safer, but are against a total ban. The new findings appear in Translational Behavior
- Men, New Technologies Drive Growth in Body Contouring Markethttps://practicaldermatology.com/news/men-new-technologies-drive-growth-in-body-contouring-market/2458467/The body contouring market is set to rise from $671.8 million in 2015 to more than $1.1 billion by 2022, representing a compound annual growth rate of 7.9%, according to research and consulting firm
- BTL Aesthetics Announces FDA Clearance for Thighshttps://practicaldermatology.com/news/btl-aesthetics-announces-fda-clearance-for-thighs/2458475/The FDA awarded BTL Aesthetics a new designation for it non-invasive fat reduction treatment, BTL Vanquish ME—the treatment is now FDA-cleared for the circumferential reduction of the abdomen and thighs. The clearance was secured following several rounds of clinical testing to provide ample
- UofL Dermatology Chief Tapped by ACCMEhttps://practicaldermatology.com/news/uofl-dermatology-chief-tapped-by-accme/2458477/Jeffrey P. Callen, MD, chief of the Division of Dermatology at the University of Louisville School of Medicine in Kentucky, has been elected to serve on the Accreditation Review Committee (ARC) of the Accreditation Council of Continuing Medical Education (ACCME).
- Mission Pharmacal Expands Dermatology Commitment with the Acquisition of GlyDermhttps://practicaldermatology.com/news/mission-pharmacal-expands-dermatology-commitment-with-the-acquisition-of-glyderm/2458487/Espada Dermatology, Inc, a wholly-owned subsidiary of Mission Pharmacal Company, purchased the GlyDerm line of skin care products from Lautus Pharmaceuticals, LLC. Prior to this acquisition, Mission offered prescription dermatological products solely through Mission Dermatology